Recent Price Movement and Market Context
The stock has experienced a consecutive two-day fall, accumulating a loss of 1.25% over this brief period. This decline contrasts with the broader Sensex index, which has posted positive returns over the past week and month, gaining 0.65% and 1.43% respectively. Apollo Hospitals’ one-week return of -1.20% and one-month return of -5.71% indicate a recent weakness that diverges from the general market trend. Year-to-date, the stock is marginally down by 0.76%, while the Sensex has advanced by 8.96%, highlighting a relative underperformance in the current calendar year.
On the day in question, the stock traded within a narrow range of ₹69.85, suggesting limited volatility but also a lack of strong buying interest. The share price remains above its 200-day moving average, a traditional indicator of long-term support, yet it is trading below its shorter-term moving averages including the 5-day, 20-day, 50-day, and 100-day averages. This technical positioning may be contributing to cautious sentiment among traders and investors.
Investor participation has notably declined, with delivery volumes on 01 Dec falling by 42.85% compared to the five-day average. This drop in trading activity could be signalling reduced enthusiasm or uncertainty among shareholders, which often precedes price softness. Despite this, liquidity remains adequate, with the stock capable of supporting trades worth approximately ₹3.87 crore based on recent average volumes.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Fundamental Strengths Supporting the Stock
Despite the recent price softness, Apollo Hospitals continues to demonstrate robust operational and financial metrics. The company boasts a high return on capital employed (ROCE) of 16.84%, reflecting efficient management and strong profitability. Its ability to service debt is also commendable, with a low Debt to EBITDA ratio of 1.48 times, indicating manageable leverage and financial stability.
Long-term growth remains healthy, with net sales expanding at an annual rate of 16.66% and operating profit growing by 37.14%. The firm has reported positive results for eight consecutive quarters, underscoring consistent performance. Notably, the latest half-year ROCE stands at 16.11%, operating profit to interest coverage ratio at 8.59 times, and quarterly net sales reaching a peak of ₹6,303.50 crore.
Valuation metrics also suggest the stock is attractively priced relative to its peers. With an enterprise value to capital employed ratio of 7.8 and a PEG ratio of 1.5, Apollo Hospitals trades at a discount compared to historical averages in its sector. Over the past year, the stock has delivered a modest 2.64% return while profits surged by 41.3%, indicating potential for value appreciation as earnings growth continues.
The company’s market capitalisation of ₹1,04,760 crore makes it the second largest in its sector, accounting for 18.46% of the entire healthcare segment. Its annual sales of ₹23,264.70 crore represent nearly 30% of the industry, reinforcing its dominant market position.
Apollo Hospitals or something better? Our SwitchER feature analyzes this Largecap Hospital stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Balancing Short-Term Weakness with Long-Term Potential
The recent decline in Apollo Hospitals’ share price appears to be driven primarily by short-term technical factors and subdued investor participation rather than fundamental weaknesses. The stock’s underperformance relative to the Sensex and its sector over the past month and week suggests some profit-taking or cautious positioning by market participants. However, the company’s strong financial health, consistent earnings growth, and attractive valuation metrics provide a solid foundation for investors considering a medium to long-term horizon.
In summary, while Apollo Hospitals has experienced a modest pullback in early December, its underlying business performance and market standing remain robust. Investors should weigh the current price softness against the company’s proven track record and dominant sector presence before making investment decisions.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
